Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options (Q36055481)

11 August 2017

1 reference

title

Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options (English)

1 reference

11 August 2017

1 reference

1 reference

Alastair J Flint

1

1 reference

11 August 2017

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

22

1 reference

11 August 2017

101-114

1 reference

11 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200522020-00002

11 August 2017

0 references

cites work

Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder

1 reference

12 December 2020

Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo

1 reference

12 December 2020

Does cognitive-behavioural therapy influence the long-term outcome of generalized anxiety disorder? An 8–14 year follow-up of two clinical trials

1 reference

12 December 2020

Parkinson's disease and anxiety: comorbidity with depression

1 reference

12 December 2020

The natural history of depression and the anxiety disorders in older people: the Islington community study

1 reference

12 December 2020

Psychiatric morbidity in patients with chronic airflow obstruction.

1 reference

12 December 2020

Anxiety disorders in patients with Parkinson's disease

1 reference

12 December 2020

Group cognitive-behavioral therapy for generalized anxiety disorder: treatment outcome and long-term follow-up

1 reference

12 December 2020

Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder

1 reference

12 December 2020

Generalized anxiety disorder in stroke patients. A 3-year longitudinal study.

1 reference

12 December 2020

Anxiety disorders in non-demented and demented elderly patients: prevalence and correlates

1 reference

12 December 2020

Buspirone therapy in anxious elderly patients: a controlled clinical trial

1 reference

12 December 2020

Anxiety disorders in familial parkinsonism.

1 reference

12 December 2020

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

1 reference

12 December 2020

Multicenter controlled study of oxazepam in anxious elderly outpatients

1 reference

12 December 2020

Anxiety and Its Association With Depression Among Institutionalized Elderly

1 reference

12 December 2020

Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use.

1 reference

12 December 2020

Bromazepam and lorazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations

1 reference

12 December 2020

Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam.

1 reference

12 December 2020

Psychosocial stress and anxiety in senile dementia.

1 reference

12 December 2020

Anxious depression in elderly patients. Response to antidepressant treatment

1 reference

12 December 2020

Cognitive-behavioral treatment of late-life generalized anxiety disorder

1 reference

12 December 2020

Generalized anxiety and depression in primary care: prevalence, recognition, and management.

1 reference

12 December 2020

Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression

1 reference

12 December 2020

Effect of demographic and clinical variables on time to antidepressant response in geriatric depression

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder

1 reference

12 December 2020

Cognitive therapy versus applied relaxation as treatment of generalized anxiety disorder.

1 reference

12 December 2020

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Ruminative thinking in older inpatients with major depression

1 reference

12 December 2020

Treatment of generalized anxiety disorder in older adults

1 reference

12 December 2020

Anxiety and Depression as Predictors of Recurrence in Geriatric Depression: A Preliminary Report

1 reference

12 December 2020

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

12 December 2020

DSM-IV criteria for generalized anxiety disorder in older adults: distinguishing the worried from the well

1 reference

12 December 2020

Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants

1 reference

12 December 2020

Two-year outcome of elderly patients with anxious depression

1 reference

12 December 2020

Effects of anxiety disorder on impairment and recovery from stroke

1 reference

12 December 2020

Infrequency of "pure" GAD: impact of psychiatric comorbidity on clinical course.

1 reference

12 December 2020

The Guy's/Age Concern survey. Prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community

1 reference

12 December 2020

The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.

1 reference

12 December 2020

Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo.

1 reference

12 December 2020

Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone

1 reference

12 December 2020

Failure of buspirone to manage benzodiazepine withdrawal

1 reference

12 December 2020

Comorbidity of the anxiety disorders in a community-based older population in The Netherlands

1 reference

12 December 2020

Effective short-term treatment of generalized anxiety disorder with trifluoperazine.

1 reference

12 December 2020

Anxiety of Alzheimer's disease: prevalence, and comorbidity

1 reference

12 December 2020

Influence of symptoms of anxiety on treatment of depression in later life in primary care: questionnaire survey

1 reference

12 December 2020

Standard and enhanced cognitive-behavior therapy for late-life generalized anxiety disorder: two pilot investigations

1 reference

12 December 2020

Phenomenology and course of generalised anxiety disorder.

1 reference

12 December 2020

Anxiety in elderly patients. A comparison of azapirones and benzodiazepines

1 reference

12 December 2020

Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use

1 reference

12 December 2020

DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being.

1 reference

12 December 2020

Is there more dementia, depression and neurosis in New York? A comparative study of the elderly in New York and London using the computer diagnosis AGECAT.

1 reference

12 December 2020

Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys

1 reference

12 December 2020

Prevalence and course of depressive disorders in hospitalized stroke patients

1 reference

12 December 2020

Treatment outcome in suicidal vs. non-suicidal elderly patients.

1 reference

12 December 2020

Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package.

1 reference

12 December 2020

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

1 reference

12 December 2020

Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents

1 reference

12 December 2020

Benzodiazepines for depression? A review of the literature

1 reference

12 December 2020

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder

1 reference

12 December 2020

Mental disorders among the community-dwelling elderly in Dublin.

1 reference

12 December 2020

Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group

1 reference

12 December 2020

Clinical correlates of early-onset and late-onset poststroke generalized anxiety

1 reference

12 December 2020

Epidemiology and comorbidity of anxiety disorders in the elderly

1 reference

12 December 2020

The nature of generalized anxiety disorder and pathological worry: current evidence and conceptual models

1 reference

12 December 2020

Anxiety disorders after stroke: results from the Perth Community Stroke Study.

1 reference

12 December 2020

Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials

1 reference

12 December 2020

Comorbidity and risk‐patterns of depression, generalised anxiety disorder and mixed anxiety‐depression in later life: results from the AMSTEL study

1 reference

12 December 2020

Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).

1 reference

12 December 2020

The natural history of neurotic disorder in an elderly urban population. Findings from the Liverpool longitudinal study of continuing health in the community

1 reference

12 December 2020

Mood disorders in the year after first stroke

1 reference

12 December 2020

1 reference

12 December 2020

Screening for anxiety and depression in elderly medical outpatients

1 reference

12 December 2020

10.2165/00002512-200522020-00002

Identifiers

DOI

1 reference

PubMed ID

15733018

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15733018